Results 131 to 140 of about 28,841 (163)

Predictive impact of serous retinal detachment in refractory diabetic macular edema

open access: yesBMC Ophthalmology
Background Anti-vascular endothelial growth factor (VEGF) drugs are the first-line treatment option for DME management. However, part of DME was refractory to anti-VEGF medicine.
Zhuo-hua Zhou   +3 more
doaj   +1 more source

Primary treatment of diabetic macular edema

open access: yesClinical Interventions in Aging, 2009
Tushar M Ranchod, Stuart L FineScheie Eye Institute, Department, of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USAAbstract: Diabetic macular edema (DME) is a leading cause of vision loss in older Americans.
Tushar M Ranchod, Stuart L Fine
doaj  

DIAGNOSIS OF DIABETIC MACULAR EDEMA (DME) BASED ON FUNDUS FLUORESCEIN ANGIOGRAPHY (FFA) FINDINGS

open access: yesJournal of University Medical & Dental College, 2015
: PURPOSE: The present study was designed to see the Physiological changes in diabetic macular edema (DME) as assessed by fundus Fluorescein angiography (FFA) and to plan the appropriate treatment regime for the patients after assessing the specific type
Qamar Mehboob   +2 more
doaj  

Effect analysis of Ranibizumab with laser photocoagulation therapy for diabetic macular edema

open access: green, 2016
Zhixiong Chen   +4 more
openalex   +2 more sources

Changes of Estimated Glomerular Filtration Rate and Glycated Hemoglobin A1c in Diabetic Macular Edema Patients Treated by Ranibizumab and Aflibercept in the Tertiary Referral Hospital [PDF]

open access: gold, 2022
Wei-Ning Ku   +11 more
openalex   +1 more source

Vitrectomy in Diabetic Macular Edema

open access: gold, 2022
Zofia Nawrocka, Jerzy Nawrocki
openalex   +1 more source

Home - About - Disclaimer - Privacy